White Horse Update – 05/21/23

As the rider of the white horse continues conquering and to conquer, subduing the masses with experimental vaccines to cure and prevent gain-of-function viruses costing millions of lives and dollars at both ends of its creations, negligence, ignorance, and failure continues in the upper enclaves of the notorious badge of authority (crown) of wreathed serpents worn on the cotton cloaks (bows) of pestilence treachery. Trust in it and its government agencies may be weaning, but…

The money still flows!

‘Calamitous Collaboration’: Outrage Grows Over NIH’s Renewal of Grant Giving Millions to Wuhan Lab-Linked EcoHealth

From the article:

Lawmakers have condemned the U.S. National Institutes of Health’s (NIH) decision to reactivate a controversial federal grant to EcoHealth Alliance that was suspended three years ago over concerns about grant term violations.

EcoHealth, the nonprofit organization that for years prior to the COVID-19 pandemic used NIH funds to conduct coronavirus research at the Wuhan Institute of Virology in China—the Chinese facility under scrutiny for its work on dangerous bat coronaviruses—announced in a May 8 statement the new four-year grant, which is to be used to study “the risk of bat coronavirus spillover emergence.”

Under the terms of the grant (pdf), EcoHealth, which is headed by British zoologist Peter Daszak, will receive a total of $4,325,005 via NIH’s National Institute for Allergies and Infectious Diseases (NIAID), which was led by Dr. Anthony Fauci until December 2022. The award amount for 2023 is $576,290.

Rep. Brett Guthrie (R-Ky.), who chairs the House Energy and Commerce subcommittee on health, said the news was “shocking and disappointing.”

“EcoHealth Alliance not only has documented negligence, ignorance, and failures in following the rules of a taxpayer-funded grant but also is the subject of a congressional investigation on its research with the Wuhan Institute of Virology,” he told The Epoch Times. “We’re going to get answers on behalf of the American people why their money is being awarded to EcoHealth Alliance.”

EcoHealth is currently the recipient of 17 active U.S. government grants that total more than $50 million….



Judge Orders FDA to Accelerate Release of COVID-19 Vaccine Trial Data to Just 2 Years

From the article:

A federal judge in Texas ordered the Food and Drug Administration (FDA) to make public data it relied on to license COVID-19 vaccines at an accelerated rate, requiring all documents to be made public by mid-2025 rather than, as the FDA wanted, over the course of about 23.5 years.

In a May 9 decision hailed as a win for transparency by the lawyer representing the plaintiffs (the parents of a child injured by a COVID-19 vaccine) in a lawsuit (pdf) against the FDA, the agency was ordered to produce the data on Moderna’s vaccine for adults and Pfizer’s for children about 10 times faster than the agency wanted.

“Democracy dies behind closed doors,” is how U.S. District Judge Mark Pittman opened his order (pdf), which requires the FDA to produce the data on Moderna’s and Pfizer’s COVID-19 vaccines at an average rate of at least 180,000 pages per month.

The FDA had argued it would be “impractical” to release the estimated 4.8 million pages at more than between 1,000 and 16,000 pages per month, which would have taken at least 23.5 years.

Aaron Siri of Siri & Glimstad, who represents the plaintiffs in the legal action against the FDA, called the decision another win for transparency and accountability that builds on an earlier court order targeting Pfizer’s COVID-19 vaccine data for those aged 16 and older.

The January 2022 order (pdf), also issued by Pittman, forced the FDA to produce all its data on Pfizer’s COVID-19 vaccine for those aged 16 and older at a rate of 55,000 pages per month, or much faster than the 75 years the agency had sought.

“That production should be completed in a few more months,” Siri said in a statement, referring to the earlier Pfizer data for those aged 16 and up.

The latest order requires the FDA to produce all of its data on Pfizer’s COVID-19 vaccine for 12- to 15-year-olds (and Moderna’s product for adults) by June 31, 2025.

FDA officials didn’t respond by press time to a request by The Epoch Times for comment….


To late to learn what?

What is already independently known!


Johnson & Johnson COVID-19 Vaccine Becomes Unavailable in US

From the article:

One of the four COVID-19 vaccines authorized in the United States is no longer available, the nation’s public health agency says.

The Johnson & Johnson COVID-19 vaccine “is no longer available in the U.S.,” the U.S. Centers for Disease Control and Prevention (CDC) stated in a recent update.

That’s due to the vaccine expiring on May 7. Health care workers were advised to dispose of any remaining doses in accordance with regulations.

The CDC and Johnson & Johnson didn’t respond to requests for comment.

U.S. regulators first cleared the jab in February 2021, giving Americans an alternative to the messenger RNA-based Moderna and Pfizer COVID-19 vaccines. Johnson & Johnson’s vaccine became popular in part because it’s only a single dose. The messenger RNA vaccines each have a primary series of two doses.

But uptake slowed after U.S. authorities paused recommending the vaccine because of concerns about a reported link to a combination of blood clotting and low platelet levels, a condition called thrombosis with thrombocytopenia syndrome (TTS) that can cause death. About 15 percent of the post-vaccination TTS cases have been fatal. The highest number of cases have been reported among women aged 30 to 49, with approximately eight cases per one million doses reported.

Regulators limited the availability of the vaccine in 2022 because experts determined it caused TTS.

Since March, recipients have also been warned that they face an increased risk of myocarditis, or heart inflammation, and a related condition called pericarditis. All four COVID-19 vaccines authorized in the United States present an increased risk of myocarditis, primarily for young males….


When will the others go away?

Meanwhile, more truths emerge…

But few have solutions…

A Plethora of Skin Symptoms Reported After COVID Vaccination, Solution Exists

From the article:

In this series, we evaluate some of the lesser-known yet common adverse events that are appearing in the research literature and doctors’ clinics and, more importantly, how to deal with them and reduce the risks.

Previously: Musician and singer Emaline Delapaix has consulted at least 16 medical specialists, all of whom believe that her conditions are linked to the vaccine. She has been diagnosed with mast cell syndrome, a potentially deadly condition in which “everything that comes in could be an enemy,” she said.

Jeff Jackson, a man in his late 40s, is a father, son, and former construction worker who used to be self-sufficient.

Yet less than two years after developing a skin-related vaccine injury, Jackson has been cut off from friends and family and lives on social welfare and donations from strangers.

After getting a second dose of the COVID-19 mRNA vaccine at his local Walmart store, he was walking back to his apartment complex when his mother, walking behind him, noticed dark red shapes moving on the back of his head.

This occurred around 15 minutes after vaccination, Jackson said.

The red shapes moved like paraffin wax in a lava lamp, he said, although the movement was much slower.

When he removed the bandage from the injection site, Jackson described a large volume of clear fluid shooting out like a fountain. He had heard of Moderna arm, where the injected area becomes red, swollen, itchy, and may form rashes. But this was unlike anything he had seen.

Over the ensuing days to weeks, Jackson went in and out of the emergency department as plaques formed everywhere on his body.

“There wasn’t a part of my body where skin wasn’t falling off, had plaque, or was turning red,” he said. “From the top of my head to the bottom of my feet, I looked like a burn victim.”

Areas with skin folds, such as the back of his ankles, would also bleed spontaneously.

Jackson had developed lichenoid dermatitis, a skin condition typically associated with drug allergies….


And here’s something known all along!

CDC Revised Vaccine Statements: Why Common Respiratory Vaccines Give Dubious Protection

From the article:

Historically, vaccines were designed to protect against infection and transmission. However, this property does not extend to the recent respiratory viral vaccines.

While the annual influenza vaccines provide some protection against flu infections, their efficacy has left much to be desired. According to a 2023 research commentary co-authored by Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, flu vaccines have been shown only to be 14 to 60 percent effective over the last 15 flu seasons.

Furthermore, the CDC reported 36 percent efficacy for the 2021–2022 influenza vaccine against infections that required medical treatment, while the 2022–2023 vaccine is estimated to be 54 percent effective.

However, the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO) have reported that a vaccine is only considered effective if it has an efficacy of 50 percent or higher.

How well COVID-19 vaccines protect against viral infection and transmission is unknown. Neither Pfizer nor Moderna tested for transmission. Several studies have shown that during Omicron, vaccine effectiveness fell below 20 percent within six months of a person receiving the last dose. Immunity against the Delta variants also waned within weeks, but the decline was slower. Studies have also shown that the vaccines’ efficacy against symptomatic disease wanes rapidly within months of administration….


Isn’t this what they’ve done all along?

FDA Advisers Back Maternal RSV Vaccine as Pfizer Says Safety Concerns Can Be Studied Post-Approval

From the article:

Advisers to the U.S. Food and Drug Administration (FDA) voiced support on May 18 for Pfizer’s maternal RSV vaccine even after several expressed concerns over premature births.

Outside experts on the Vaccines and Related Biological Products Advisory Committee unanimously said data from two trials run by Pfizer were sufficient to support the vaccine being effective at preventing RSV disease in infants. They also voted 10–4 in the affirmative when asked if the data from the trials were sufficient to demonstrate the safety of the vaccine.

The votes set up FDA clearance for what would be the first maternal vaccine for the respiratory syncytial virus, or RSV.

Pfizer’s vaccine, a recombinant protein subunit shot, targets the RSV A and RSV B subgroups in a 120 microgram dose that would be given to pregnant women in the second or third trimester. The goal would be to relay antibodies against RSV to fetuses, conferring protection that is supposed to last through the first year of life.

The vaccine was 81.8 percent efficacious through 90 days after birth against severe lower respiratory tract illness due to RSV. The efficacy dropped to 69.4 percent after another 90 days.

For any RSV-positive medically attended lower respiratory tract illness, the vaccine started at 57.1 percent efficacy and dropped to 51.3 percent over the same timeframe, according to data from a phase 3 trial that included about 3,500 vaccinated pregnant women.

The efficacy for medically attended lower respiratory tract illness from any cause was just 2.5 percent at 180 days and 5.1 percent at 360 days.

FDA staffers said in a briefing document that the trial showed “successful vaccine efficacy, and the advisers seconded that view with their unanimous vote.

But multiple experts expressed concerns about the risk of the vaccine causing premature births, a risk found in a similar product made by GlaxoSmithKline that prompted the company to halt testing in 2022.

In Pfizer’s trial, there were more premature deliveries in the vaccinated arm than the placebo arm—5.7 percent in the former versus 4.7 percent in the latter.

“That is hanging over this program,” Dr. Paul Offit, one of the FDA’s advisers, said during Thursday’s meeting.

The FDA declined to comment on the issue during the meeting, though staffers wrote in a brief that there was “potential uncertainty” regarding premature births….


Of course!

Jab now and then get results!

A lab rat mentality!?!?

For this cause there was trust in a lie!

And now the delusion is haunting.

Come out of Babylon for her judgement is near!

eze33, LOLGB+

Leave a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s